Figure 2: Y-shaped binding cavity with the binding sites explored using the crystal structure of the heterodimer of the human RXRα and PPARγ ligand binding domains, respectively, bound with 9-cis retinoic acid and GI262570, a full agonist and coactivator peptides (PDB:1FM9).